Latest Funding And Capital News

Spacetalk Ltd has raised $3 million through convertible notes from its largest shareholder and converted $1 million of secured debt, positioning the company for international growth and new product development.

Vulcan Energy Resources has raised €30 million through a strategic placement led by BNP Paribas’ Clean Energy Solutions Fund to advance critical development stages of its Phase One Lionheart lithium project.

Lowell Resources Fund updates its estimated FY25 dividend to AUD 0.0274 per unit with a partly franked component, alongside a revised distribution reinvestment plan price at a 10% discount.

ARC Funds Limited has completed a $750,000 equity raise through a placement and director share subscription, supporting its recent acquisitions and growth strategy.

Vitasora Health has completed the first tranche of its $11 million capital raise, positioning the company to fund growth initiatives and reach cash flow breakeven in the second half of fiscal 2026.

Trigg Minerals has raised A$12.5 million from institutional and strategic investors to accelerate development of its Antimony Canyon Project in Utah, positioning itself as a key supplier in the US critical minerals market amid soaring antimony prices.

SRJ Technologies Group has voluntarily suspended its ASX trading as it prepares for a pivotal capital raising and shareholder meeting to secure its financial future.

Horseshoe Metals Limited will lift its trading suspension immediately following the release of details on a new capital raising, signaling a pivotal moment for the base metals miner.

Enterprise Metals Ltd is set to raise approximately $780,000 through a share placement aimed at advancing drilling activities across its key Western Australian projects.

InvestSMART Funds Management has updated the Distribution Reinvestment Plan rules for the Intelligent Investor Equity Growth Fund Active ETF, effective July 1, 2025, enhancing unitholder flexibility and fund capital management.

Actinogen Medical has locked in up to $13.8 million in non-dilutive funding tied to its R&D tax incentives, bolstering its cash position as it advances a pivotal Alzheimer’s disease clinical trial.

Lodestar Minerals announces a $2.2 million two-tranche capital raising to advance its Chile exploration projects and evaluate new opportunities, signaling renewed investor confidence.